The Battle for the Surgical Robot Market Has Begun.
01
Intuitive Surgical Releases Q1 Financial Report
Da Vinci Installation Volume Reaches New High
4On the 21st, Intuitive Surgical released its first-quarter financial report for 2026. The global leader in surgical robotics once again delivered impressive results.
2026Q1，Intuitive SurgicalRevenue of $2.77 billion, a year-on-year increase of 23%, significantly exceeding previous capital market expectationsPerformance,Adjusted net profit reached 9.01 billion US dollars, a year-on-year increase of 36.2%.。
Source: Intuitive Surgical Official Website
This yearThe First Quarter,Intuitive Surgical Installation431 Sets of Da Vinci Systems, an increase of 17.4% compared to 367 units in the same period last year.Among them,Da Vinci 5232 systems were installed, accounting for 54% of the total installations in the quarter.，The new generation product isAccelerate penetration,Cumulative Installations of the Ion System Break the 1,000 Mark.
The New CEO of Intuitive Surgical Taking Office in 2025Dave Rosa stated, "We are pleased with the company's performance this quarter, which was characterized by the expanded adoption of da Vinci, Ion, and the digital platform."
According to the financial report,ItsGlobal Total Surgical Volume (Da Vinci + Ion System) Increased Year-over-Year17%, In addition to providing a foundation for the growth in the number of installations, it also accelerates the stable scaling of complementary products and services. During this reporting period,Intuitive Surgical's "consumables + system" revenue has accounted for over 80% of total revenue.
The global surgical robot market has gradually entered a mature development phase, with the industry scale continuously expanding. Frost & Sullivan predicts,To 2The global surgical robot market size will reach 28.5 billion US dollars in 2025.Among them, laparoscopic surgical robots account for the largest sub-sector, with a share exceeding 60%.。Notably, the Matthew Effect remains significant within the industry. According to an analysis report by Markets&Markets, in 2024, Intuitive Surgical's Da Vinci surgical robot will account for approximately 60% of the global market share, while international brands such as Stryker, Medtronic, and Johnson & Johnson will collectively hold less than 20%.In light of the latest financial report,Intuitive Surgical still maintains its dominance in this field. However, driven by the incremental market,A group of Chinese and foreign enterprises are increasingly targeting this blue ocean market, among which there are aggressive representatives taking a head-on approach, as well as long-term strategists opting for differentiated competition.Surgical robots: This blue ocean market has seen new changes.02
Giant Encirclement and Domestic Pursuit
The Revolution of Surgical Robots is Imminent
Backed by substantial financial reserves and channel advantages, several international medical device giants have adopted a rather direct strategy, challenging the core territory of the da Vinci system.MedtronicAnnounced in February this yearHugoSoft Tissue Robotic Surgical System Successfully Conducts First Commercial Surgeries in the U.S., Marking the Official Start of Its Commercialization Process in America;Johnson & JohnsonThe Ottava system, under its umbrella, was also launched in 2026.Monthly SubmissionInnovative Medical Device Market Application,Officially entering the core track of surgical robotics.Compared with Intuitive Surgical, medical device leaders like Medtronic and Johnson & Johnson have accumulated years of brand reputation across different departments and possess extensive production line experience and market influence in the consumables field. Relying on their advantages in the entire industry chain and strong channel capabilities, they can achieve rapid penetration.The potential market that Intuitive Surgical has yet to reach.Stryker andSmith & NephewThey are more specialized in orthopedics and other areas of their own competitive advantage, and do not yet constitute direct competition with Intuitive Surgical. They have already secured key shares in niche markets.Chinese companies started relatively late, and do not have the extensive hospital recognition that Medtronic and Johnson & Johnson enjoy, and there is an objective gap in technology compared to the da Vinci system.In recent years, driven by national policy support and continuous research and development, domestically produced surgical robots have rapidly risen, but most still choose to break through in niche markets and adopt a cost-performance superiority strategy.For example, inIn the field of orthopedic surgical robots, domestically produced ones have already taken a dominant position in the local market. According toAccording to the statistics from the Medical Engineering Research Society, by the end of 2025, there will be 51 orthopedic surgical robot companies in China (40 Chinese companies and 11 foreign companies)., accounting for 78.4% of domestic production`, and continue to enter), obtaining a total of 84 registration certificates, covering three major types: joints, spine, and trauma,`Among them,TINAVI is Made in ChinaOn behalf of the company, according toMedical Equipment Data ExcellenceStatistics 2025,TINAVI Maintains the First Place in the Market Share of Orthopedic Surgical Robots in China, with a market share exceeding 40%. The latest earnings report shows that its full year of 2025Operating revenue was approximately 283 million yuan, representing a year-on-year increase of 58.38%.InIn the field of endoscopy, the voice of domestically produced products is also rapidly rising.MicroPort, Minimally Invasive,SuruiThe product portfolio continues to expand, with dense installations and operations in top-tier tertiary hospitals in China.ConorthLatecomers are also catching up rapidly, and the scale of clinical validation continues to expand.From the procurement data, the procurement price of domestically produced endoscopic surgical robots is only 1/3 to 1/2 that of Da Vinci, and the cost of accompanying instruments and consumables is also much lower than imported products. At the CMEF event this spring, the booths of the aforementioned domestically produced surgical robot brands were crowded with visitors, and interest from the hospital sector in Chinese-produced options has significantly increased compared to previous years.In January this year, the national medical insurance department issued the "Guidelines for the Establishment of Medical Service Price Projects for Surgical and Therapeutic Auxiliary Operations (Trial)", which standardizes the pricing of medical service projects involving auxiliary operations such as "surgical robots" and "remote surgery". Currently, regions like Hunan have officially followed suit, and the clarification of hospital charges will accelerate the arrival of a procurement wave for surgical robots in China.Similar to the United States, as the market gradually matures, China's medical device giants are also beginning to enter the surgical robot arena.Mindray MedicalOfficially announced the surgical robot plan in March this year,United Imaging GroupUnder its umbrellaThe thoracoabdominal endoscopic surgery system was released last year.12Month31Approved on [Date].The entry of major players, coupled with market expansion, has ushered the surgical robot sector into a new phase of intense competition.END
Content Communication: nrzx0321Business Cooperation: 13520085521
